Saudi Pharmaceutical Journal · 2016 · 39 citations · 21 references
Life SciencesBiochemistryPharmacologyCellular BiochemistryCellular MetabolismMetabolismFatty Acid MetabolismLipid ChemistryLipid MetabolismLipid StorageTriglyceride MetabolismDose-dependent InductionHepatic Lipid AccumulationIntracellular Lipid AccumulationLipid AccumulationTriglyceride Lowering
This experiment aimed to evaluate the capacities of two types of chitooligosaccharides (COS) with different molecular weights for the ability to eliminate lipid accumulation in hepatocytes. We have established a lipid accumulation model in HepG2 cells for these studies in vitro, which was established by induction with oleic acid. The capacity of COS to eliminate lipid accumulation was evaluated using three metrics: the thiazolyl blue dye absorbance (MTT value), the morphology of intracellular lipid droplets and the triglyceride level (TG). Two types of COS with different molecular weights (1000 Da and 3000 Da) can significantly reduce intracellular lipid accumulation and decrease TG content in HepG2 cells, in a dose-dependent fashion. We found that low molecular weight COS is more efficacious than high molecular weight COS. Two types of COS can eliminate lipid accumulation induced by oleic acid in HepG2 cells, leading to an obvious hypolipidemic effect in vitro. These results suggest that COS may be effective preventive agents in fatty liver disease.
21
Anti-Obese Effect of Glucosamine and Chitosan Oligosaccharide in High-Fat Diet-Induced Obese Rats
Lanlan Huang, Jian Chen, Peiqiu Cao et al. · Marine Drugs · 2015 · 138 citations · Full text
Lipid-lowering effect of berberine in human subjects and rats
Yueshan Hu, Erik A. Ehli, Julie M. Kittelsrud et al. · Phytomedicine · 2012 · 136 citations
Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease
Ying Chen, Min Xu, Tiange Wang et al. · Atherosclerosis · 2015 · 79 citations